There are 2789 resources available
103P - Rate of BRCA1/2 pathogenic variants according to family and personal history of cancer in a large cohort of triple-negative breast cancer (TNBC) patients (pts) younger than 60 years of age
Presenter: Stefania Zovato
Session: ePoster Display
104P - Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib
Presenter: Jesus Garcia-Foncillas
Session: ePoster Display
210P - TACH101, a first-in-class KDM4 inhibitor for treatment of triple-negative breast cancer
Presenter: Frank Perabo
Session: ePoster Display
211P - Genetic and immunologic characteristics in Chinese breast patients with different HER2 mutation types
Presenter: Hui Cao
Session: ePoster Display
212P - HER2-low breast cancer: Evolution from primary tumor to residual disease after neoadjuvant treatment
Presenter: Federica Miglietta
Session: ePoster Display
213P - Predictive markers of cardiotoxicity associated with breast cancer treatment
Presenter: Ines Nogueira Costa
Session: ePoster Display
214P - Landscape of homologous recombination repair gene mutations in different molecular subtypes of breast cancer
Presenter: Yan Xu
Session: ePoster Display
215P - Somatic mutations and gene expression of neuroendocrine pathways in aggressive and nonaggressive breast cancer
Presenter: Kejia Hu
Session: ePoster Display
216P - Prognostic role of Ki67 cutoff and mPEPI score for neoadjuvant ‘chemotherapy’ in locally advanced HER2-negative ‘luminal’ breast cancer
Presenter: Mutlu Dogan
Session: ePoster Display
217P - The impact of obesity on the survival outcomes of women with breast cancer that achieve pathological complete response
Presenter: Mariana Roman-Zamudio
Session: ePoster Display